Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingfeng Yu

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Chemical Information and Modeling|February 14, 2017
In Search of Novel CDK8 Inhibitors by Virtual ScreeningMalika Kumarasiri, Theodosia Teo, Mingfeng Yu, et al.
ACS Omega|May 5, 2025
PEI-Reinforced GO/g-C<sub>3</sub>N<sub>4</sub> Composite Membrane for Salt SeparationWenbiao Zheng, Mingfeng Yu, Sujuan Yang, et al.
Chemistryopen|August 23, 2016
Synthesis and Evaluation of 1,8-Disubstituted-Cyclam/Naphthalimide Conjugates as Probes for Metal IonsJoseph K-H Wong, Sandra Ast, Mingfeng Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2010
Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cellsJunfen Jiang, Mei Zhao, Aiying Zhang, et al.
Chemmedchem|March 29, 2014
Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluationSarah Diab, Theodosia Teo, Malika Kumarasiri, et al.
Molecular Pharmacology|August 14, 2015
Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2Sunita K C Basnet, Sarah Diab, Raffaella Schmid, et al.
Molecules (Basel, Switzerland)|April 13, 2023
Discovery of <i>N</i>,4-Di(1<i>H</i>-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and EvaluationBiruk Sintayehu Fanta, Jimma Lenjisa, Theodosia Teo, et al.
British Journal of Pharmacology|August 12, 2017
Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin-dependent kinases 4 and 6 as anticancer agentsSolomon Tadesse, Laychiluh Bantie, Khamis Tomusange, et al.
Inorganic Chemistry|November 25, 2011
Copper, nickel, and zinc cyclam-amino acid and cyclam-peptide complexes may be synthesized with "click" chemistry and are noncytotoxicMingfeng Yu, Jason R Price, Paul Jensen, et al.
Bioorganic & Medicinal Chemistry|January 27, 2023
2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Design, synthesis & evaluationBiruk Sintayehu Fanta, Laychiluh Mekonnen, Sunita K C Basnet, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Chemical Information and Modeling|February 14, 2017
In Search of Novel CDK8 Inhibitors by Virtual ScreeningMalika Kumarasiri, Theodosia Teo, Mingfeng Yu, et al.
ACS Omega|May 5, 2025
PEI-Reinforced GO/g-C<sub>3</sub>N<sub>4</sub> Composite Membrane for Salt SeparationWenbiao Zheng, Mingfeng Yu, Sujuan Yang, et al.
Chemistryopen|August 23, 2016
Synthesis and Evaluation of 1,8-Disubstituted-Cyclam/Naphthalimide Conjugates as Probes for Metal IonsJoseph K-H Wong, Sandra Ast, Mingfeng Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 3, 2010
Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cellsJunfen Jiang, Mei Zhao, Aiying Zhang, et al.
Chemmedchem|March 29, 2014
Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluationSarah Diab, Theodosia Teo, Malika Kumarasiri, et al.
Molecular Pharmacology|August 14, 2015
Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2Sunita K C Basnet, Sarah Diab, Raffaella Schmid, et al.
Molecules (Basel, Switzerland)|April 13, 2023
Discovery of <i>N</i>,4-Di(1<i>H</i>-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and EvaluationBiruk Sintayehu Fanta, Jimma Lenjisa, Theodosia Teo, et al.
British Journal of Pharmacology|August 12, 2017
Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin-dependent kinases 4 and 6 as anticancer agentsSolomon Tadesse, Laychiluh Bantie, Khamis Tomusange, et al.
Inorganic Chemistry|November 25, 2011
Copper, nickel, and zinc cyclam-amino acid and cyclam-peptide complexes may be synthesized with "click" chemistry and are noncytotoxicMingfeng Yu, Jason R Price, Paul Jensen, et al.
Bioorganic & Medicinal Chemistry|January 27, 2023
2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: Design, synthesis & evaluationBiruk Sintayehu Fanta, Laychiluh Mekonnen, Sunita K C Basnet, et al.
Pageof 6